Irosustat

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameIrosustat
Drug Alias NameIrostustat艾芦司他irosustatum艾苏司他oristusane +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCarbonic anhydrase II inhibitorsSteryl-sulfatase inhibitors
TargetsCarbonic anhydrasesSteryl-sulfatase
Therapy Area/IndicationsProstatic NeoplasmsEndometrial NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[15] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIpsen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIpsen
Active IndicationsN/A
Inactive IndicationsProstatic NeoplasmsEndometrial NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksKEGG